MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1

被引:45
|
作者
Tao, Jun [1 ]
Cong, Haibo [2 ]
Wang, Hongyan [2 ]
Zhang, Daoqiang [2 ]
Liu, Chuanjie [2 ]
Chu, Hongxia [2 ]
Qing, Qianfeng [2 ]
Wang, Kunzheng [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian 710004, Shaanxi, Peoples R China
[2] Weihai Cent Hosp, Weihai City Key Lab Autoimmun, Weihai 264400, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; FOXD1; miR-30a-5p; Cell proliferation; Cell migration; BREAST-CANCER; GROWTH; SUPPRESSES; APOPTOSIS; MICRORNAS; PROGNOSIS; GENETICS; STAND;
D O I
10.1016/j.bbrc.2018.06.121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite a number of studies have emphasized the extensive role of microRNA (miRNA) in the development of multiple cancers, the role of miR-30a-5p in the progression of osteosarcoma (OS) and the underlying mechanism are still limited. We detected the expression level of MiR-30a-5p and forkhead box D1 (FOXD1) in Clinical OS specimens and found that miR-30a-5p was significantly decreased while FOXD1 was markedly increased. Dual luciferase assay confirmed that FOXD1 was directly regulated by miR-30a-5p. In vitro assay showed that inhibitior of FOXD1 suppressed cell proliferation, migration and invasion in MG63 and U2OS cells, while overexpression of FOXD1 promoted OS cell proliferation and migration. In vivo assay further showed the inhibition of tumor growth after knockdown of FOXD1. These results suggested that FOXD1 might play key roles in OS development and progression, and was negatively regulated by miR-30a-5p in OS. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 50 条
  • [31] MiR-193b enhanced proliferation and migration and inhibits apoptosis through targeting RAB7A in osteosarcoma cell
    Zhang, Yuan-yuan
    Xu, Hai-yan
    Dai, Jing-jing
    MOLECULAR & CELLULAR TOXICOLOGY, 2021, 17 (01) : 69 - 78
  • [32] miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1
    Yuan, Long
    Yuan, Peng
    Yuan, Huijuan
    Wang, Zhenlei
    Run, Zengci
    Chen, Guanglong
    Zhao, Peng
    Xu, Benling
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (01): : 159 - 172
  • [33] miR-425-5p promotes cell proliferation, migration and invasion by directly targeting FOXD3 in hepatocellular carcinoma cells
    Wu, Hewen
    Shang, Jia
    Zhan, Weili
    Liu, Junping
    Ning, Huibin
    Chen, Ning
    MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1883 - 1892
  • [34] miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1
    Cai, Wei
    Xu, Yong
    Yin, Jian
    Zuo, Wenshan
    Su, Zhen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (05) : 3781 - 3788
  • [35] MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A
    Dai, Jinliang
    Lu, Lin
    Kang, Lixin
    Zhang, Jian
    HUMAN CELL, 2021, 34 (02) : 624 - 633
  • [36] MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma
    Han, Chaofan
    Wang, Wenbo
    MOLECULAR MEDICINE REPORTS, 2018, 17 (03) : 4777 - 4784
  • [37] Actein Inhibits Cell Proliferation and Migration in Human Osteosarcoma
    Chen, Zhi
    Wu, Jingdong
    Guo, Qinghao
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1609 - 1616
  • [38] MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells
    Zhao, Yue-Sheng
    Yang, Wei-Chao
    Xin, Hong-Wei
    Han, Ji-Xia
    Ma, Su-Gang
    YONSEI MEDICAL JOURNAL, 2019, 60 (02) : 148 - 157
  • [39] miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells
    Niu, Junjie
    Sun, Yibao
    Guo, Qiaoge
    Niu, Dongju
    Liu, Bo
    DISEASE MARKERS, 2016, 2016 : 1 - 8
  • [40] miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2
    Jiang, Pan
    Mao, Lianghao
    Lei, Xuan
    Luo, Chunshan
    Zhang, Yiming
    Zhong, Xinyu
    Yin, Zhenyu
    Xu, Xiaofeng
    Li, Dapeng
    Zheng, Qiping
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3464 - +